Websitewww.progena.com
www.progena.com
www.progena.comAllergena for Pets
- Manufacturer
- Meditrend, Inc. DBA Progena Professional Formulations
- Effective date
- 2012-10-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:04:03
Label at a glance#
ProductAllergena for Pets
Active ingredientECHINACEA, UNSPECIFIED, BETULA PAPYRIFERA POLLEN, JUNIPERUS ASHEI POLLEN, QUERCUS RUBRA POLLEN, ARTEMISIA VULGARIS POLLEN, AMARANTHUS RETROFLEXUS POLLEN, AMBROSIA ARTEMISIIFOLIA POLLEN, SALSOLA TRAGUS POLLEN, PASPALUM NOTATUM POLLEN, CYNODON DACTYLON POLLEN, POA ANNUA POLLEN, LOLIUM PERENNE POLLEN, PHLEUM PRATENSE POLLEN, DERMATOPHAGOIDES PTERONYSSINUS, DERMATOPHAGOIDES FARINAE, BAPTISIA TINCTORIA ROOT, GOLDENSEAL, MYRRH, NASTURTIUM OFFICINALE, PHYTOLACCA AMERICANA ROOT, FENUGREEK LEAF, CALENDULA OFFICINALIS FLOWERING TOP, TOXICODENDRON PUBESCENS LEAF, DELPHINIUM STAPHISAGRIA SEED, URTICA URENS
Label structure9 sections
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients:Echinacea 3X HPUS;*Trees, Weeds, Grasses (6X, 12X, 30X) and *Dust Mites (9X, 12X, 15X, 30X);Drainage Remedies: Baptisia tinctoria 3X HPUS; Hydrastis canadensis 3X HPUS; Myrrha 3X HPUS; Nasturtium aquaticum 3X HPUS; Phytolacca decandra 3X HPUS; Trigonella foenum-graecum 3X.Skin Remedies:Calendula officinalis 3X; Rhus tox 6X; Staphysagria 6X; Urtica urens 3X;
OTC - PURPOSE SECTION
Purpose: Relief from Itching, Sneezing, Coughing and Skin Irritation.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep Out of Reach of Children. In case of overdose, get medical help or contact a
Poison Control Center right away.
INDICATIONS & USAGE SECTION
Use: This product is a Homeopathic Dilution formulated to improve immunity for the temporary relief of allergies.
WARNINGS SECTION
Warnings:
- Use Only as directed.
- Stop use and ask a veterinarian ifsymptoms worsen or do not improve after 5 days.
- If nursing,, consult a veterinarian before use.
DOSAGE & ADMINISTRATION SECTION
Directions: • Shake Well Before Use. • (1-20 lbs) 4-6 drops three times daily. • (21-60 lbs) 8-10 drops three times daily. • (61 lbs and above) 10-15 drops three times daily. 10-15 drops three times daily.
OTHER SAFETY INFORMATION
Other Information: Do not use if TAMPER EVIDENT seal around neck of bottle is missing or broken.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: USP Purified Water and Vegetable Glycerin.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Manufactured for Progena Professional Formulations
4820 Eubank Blvd. NE, ABQ, NM 87111, www.progena.com
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62713-943-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-16a1-f424-e053-dadaa90a57ce | Allergena for Pets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62713-943-01 | Allergena for Pets | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AMARANTHUS RETROFLEXUS POLLEN | ACTIVE INGREDIENT | 73B14PX5FW | 1 | |
| AMBROSIA ARTEMISIIFOLIA POLLEN | ACTIVE INGREDIENT | K20Y81ACO3 | 1 | |
| ARTEMISIA VULGARIS POLLEN | ACTIVE INGREDIENT | ANT994T71D | 1 | |
| BAPTISIA TINCTORIA ROOT | ACTIVE INGREDIENT | 5EF0HWI5WU | 1 | |
| BETULA PAPYRIFERA POLLEN | ACTIVE INGREDIENT | 3538FNV8AY | 1 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | 18E7415PXQ | 1 | |
| CYNODON DACTYLON POLLEN | ACTIVE INGREDIENT | 175F461W10 | 1 | |
| DELPHINIUM STAPHISAGRIA SEED | ACTIVE INGREDIENT | 00543AP1JV | 1 | |
| DERMATOPHAGOIDES FARINAE | ACTIVE INGREDIENT | PR9U2YPF3Q | 1 | |
| DERMATOPHAGOIDES PTERONYSSINUS | ACTIVE INGREDIENT | 57L1Z5378K | 1 | |
| ECHINACEA, UNSPECIFIED | ACTIVE INGREDIENT | 4N9P6CC1DX | 1 | |
| FENUGREEK LEAF | ACTIVE INGREDIENT | 487RI96K8Z | 1 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 1 | |
| JUNIPERUS ASHEI POLLEN | ACTIVE INGREDIENT | 544F8MEY0Y | 1 | |
| LOLIUM PERENNE POLLEN | ACTIVE INGREDIENT | 4T81LB52R0 | 1 | |
| MYRRH | ACTIVE INGREDIENT | JC71GJ1F3L | 1 | |
| NASTURTIUM OFFICINALE | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| PASPALUM NOTATUM POLLEN | ACTIVE INGREDIENT | V003SHB7VK | 1 | |
| PHLEUM PRATENSE POLLEN | ACTIVE INGREDIENT | 65M88RW2EG | 1 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE INGREDIENT | 11E6VI8VEG | 1 | |
| POA ANNUA POLLEN | ACTIVE INGREDIENT | 7U437HHU5C | 1 | |
| QUERCUS RUBRA POLLEN | ACTIVE INGREDIENT | SVW19ET93C | 1 | |
| SALSOLA TRAGUS POLLEN | ACTIVE INGREDIENT | V174354MDI | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| URTICA URENS | ACTIVE INGREDIENT | IHN2NQ5OF9 | 1 | |
| AMARANTHUS RETROFLEXUS POLLEN | ACTIVE MOIETY | 73B14PX5FW | 1 | |
| AMBROSIA ARTEMISIIFOLIA POLLEN | ACTIVE MOIETY | K20Y81ACO3 | 1 | |
| ARTEMISIA VULGARIS POLLEN | ACTIVE MOIETY | ANT994T71D | 1 | |
| BAPTISIA TINCTORIA ROOT | ACTIVE MOIETY | 5EF0HWI5WU | 1 | |
| BETULA PAPYRIFERA POLLEN | ACTIVE MOIETY | 3538FNV8AY | 1 | |
| CALENDULA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | 18E7415PXQ | 1 | |
| CYNODON DACTYLON POLLEN | ACTIVE MOIETY | 175F461W10 | 1 | |
| DELPHINIUM STAPHISAGRIA SEED | ACTIVE MOIETY | 00543AP1JV | 1 | |
| DERMATOPHAGOIDES FARINAE | ACTIVE MOIETY | PR9U2YPF3Q | 1 | |
| DERMATOPHAGOIDES PTERONYSSINUS | ACTIVE MOIETY | 57L1Z5378K | 1 | |
| ECHINACEA, UNSPECIFIED | ACTIVE MOIETY | 4N9P6CC1DX | 1 | |
| FENUGREEK LEAF | ACTIVE MOIETY | 487RI96K8Z | 1 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 1 | |
| JUNIPERUS ASHEI POLLEN | ACTIVE MOIETY | 544F8MEY0Y | 1 | |
| LOLIUM PERENNE POLLEN | ACTIVE MOIETY | 4T81LB52R0 | 1 | |
| MYRRH | ACTIVE MOIETY | JC71GJ1F3L | 1 | |
| NASTURTIUM OFFICINALE | ACTIVE MOIETY | YH89GMV676 | 1 | |
| PASPALUM NOTATUM POLLEN | ACTIVE MOIETY | V003SHB7VK | 1 | |
| PHLEUM PRATENSE POLLEN | ACTIVE MOIETY | 65M88RW2EG | 1 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE MOIETY | 11E6VI8VEG | 1 | |
| POA ANNUA POLLEN | ACTIVE MOIETY | 7U437HHU5C | 1 | |
| QUERCUS RUBRA POLLEN | ACTIVE MOIETY | SVW19ET93C | 1 | |
| SALSOLA TRAGUS POLLEN | ACTIVE MOIETY | V174354MDI | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| URTICA URENS | ACTIVE MOIETY | IHN2NQ5OF9 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Allergena for Pets
- GLYCERIN
- WATER
- ECHINACEA, UNSPECIFIED
- BETULA PAPYRIFERA POLLEN
- JUNIPERUS ASHEI POLLEN
- QUERCUS RUBRA POLLEN
- ARTEMISIA VULGARIS POLLEN
- AMARANTHUS RETROFLEXUS POLLEN
- AMBROSIA ARTEMISIIFOLIA POLLEN
- SALSOLA TRAGUS POLLEN
- PASPALUM NOTATUM POLLEN
- CYNODON DACTYLON POLLEN
- POA ANNUA POLLEN
- LOLIUM PERENNE POLLEN
- PHLEUM PRATENSE POLLEN
- DERMATOPHAGOIDES PTERONYSSINUS
- DERMATOPHAGOIDES FARINAE
- BAPTISIA TINCTORIA ROOT
- GOLDENSEAL
- MYRRH
- NASTURTIUM OFFICINALE
- PHYTOLACCA AMERICANA ROOT
- FENUGREEK LEAF
- CALENDULA OFFICINALIS FLOWERING TOP
- TOXICODENDRON PUBESCENS LEAF
- DELPHINIUM STAPHISAGRIA SEED
- URTICA URENS
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62713-943 | 62713-943-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 839b8761-0485-482e-a0a7-f1d557f1b7d6 | 42d26711-4fde-4835-80b1-0a72cc1570d7 | 2012-10-16 | Warnings | 839b8761-0485-482e-a0a7-f1d557f1b7d6 42d26711-4fde-4835-80b1-0a72cc1570d7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.